Christie Edward M III 4

What Happened
Christie Edward M III, a non-employee director of Encompass Health Corporation (EHC), received awards/acquisitions totaling 259 shares in mid‑July 2026. On July 15, 2026 he was credited 11 restricted stock units (RSUs) in connection with the company’s $0.19/share dividend (reported at $0.00 per share). On July 16, 2026 he acquired 248 shares at a reported weighted average price of $112.43 per share (total value reported $27,883). These transactions are awards/acquisitions (code A) rather than sales.

Key Details

• Transaction dates and amounts:
  • 2026-07-15: 11 RSUs credited (dividend-related), $0.00 per share reported.
  • 2026-07-16: 248 shares acquired at a weighted avg price $112.43; total reported = $27,883. Purchases occurred at prices ranging $112.40–$112.43 (per footnote).
• Shares owned after transaction: Not reported in this filing.
• Notable footnotes:
  • F1: 11 RSUs credited under outstanding RSU award agreements in connection with the $0.19 dividend (dividend amount / closing price calculation).
  • F2: 248 shares were purchased by the company’s Directors Deferred Stock Investment Plan using fee deferrals and reinvested dividends.
  • F3: Reported per‑share price is a weighted average; purchases spanned $112.40–$112.43.
• Filing timeliness: Form 4 filed 2026-07-16 for transactions on 2026-07-15 and 2026-07-16 — appears timely (no late filing flag).

Context

• These transactions reflect director compensation and deferral-plan activity (dividend crediting of RSUs and plan-funded share purchases), not an open‑market sale by the director.
• Transaction code "A" denotes an award/acquisition (RSUs/purchases); there was no exercise or sale reported here.
• The 248-share purchase represents modest insider buying (~$27.9k) via the company plan rather than a direct market order by the director.